There is a continued effort focused on bacterial vaginosis (BV) to improve perinatal outcome. However it seems as though, in the absence of an understanding of vaginal microbiology, there is also an effort to abort the unfavorable outcome. This seems illogical since specific treatment modalities usually are not effective when there is a lack of understanding with regard to specific etiology. Unfortunately, the pharmaceutical industry has been lead to believe than an abnormal vaginal microflora can be corrected by antibiotic treatment. Thus far, however, the antibiotic treatments advocated for treating an abnormal microflora have yet to be proven effective in restoring a healthy vaginal microflora. A concentrated effort by a group of investigators working on specific questions with regard to the microbiologic physiology and pathophysiology of the lower genital tract is definitely needed if there is to be significant progress made in this area. A cooperative research effort, combining all the groups interested in this basic question, funded by both industry and the government will likely have a greater impact on our understanding of the vaginal microflora and, eventually, lead to meaningful and successful treatment regimens.

